MedTrace Logo

Impacts of Physiotherapy Services in a Quebec Emergency Department

NCT04009369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2020-10-28

No results posted yet for this study

Summary

Emergency departments (ED) in several countries integrated physiotherapists in order to reduce wait times for patients with musculoskeletal disorders (MSKD). These initiatives have indeed reduced wait times, length of stay, time waited before seeing a professional and the prescription of unnecessary consultations and diagnostic tests. In Canada, such initiatives are marginal and their effects have not been studied.

The objectives of the project are to evaluate the effects of physiotherapy management of patients with MSKD in ED compared to usual practice on clinical course of patients, use of services and resources, and waiting time and length of stay in ED. The hypothesis is that patients presenting with a MSKD to the ED with direct access to a physiotherapist will have better clinical outcomes and that use of services, waiting time, and length of stay are going to be inferior to those of the EP group.

Conditions

Interventions

OTHER

Direct access to a PT

Direct access to a PT in the ED immediately after triage and prior to physician assessment.

Sponsors & Collaborators

  • CHU de Quebec-Universite Laval

    collaborator OTHER

  • Integrated University Health and Social Services Center of the Capitale-Nationale

    collaborator OTHER

  • Laval University

    collaborator OTHER

  • Rose Gagnon

    lead OTHER

Principal Investigators

  • Rose Gagnon, MPT, MSc(c) · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2019-06-27
Completion
2019-06-27

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04009369 on ClinicalTrials.gov